Attal, S. A Response to: Letter to the Editor Regarding “Tafamidis 61 mg Patient Characteristics and Persistency? A Retrospective Analysis of German Statutory Health Insurance Data (IQVIA™ LRx)”. Adis, Springer Healthcare.
Chicago Style (17th ed.) CitationAttal, Sepideh. A Response to: Letter to the Editor Regarding “Tafamidis 61 mg Patient Characteristics and Persistency? A Retrospective Analysis of German Statutory Health Insurance Data (IQVIA™ LRx)”. Adis, Springer Healthcare.
MLA (9th ed.) CitationAttal, Sepideh. A Response to: Letter to the Editor Regarding “Tafamidis 61 mg Patient Characteristics and Persistency? A Retrospective Analysis of German Statutory Health Insurance Data (IQVIA™ LRx)”. Adis, Springer Healthcare.
Warning: These citations may not always be 100% accurate.